Literature DB >> 11971128

Optimizing health outcomes in active epilepsy.

Frank Gilliam1.   

Abstract

Article abstract Epilepsy is a chronic condition with complex effects on a person's social, vocational, and psychological function. Recent advances in methods and instruments to assess subjective health status and patient preferences have provided important data on health outcomes in epilepsy. For many patients that do not respond to initial trials of antiepileptic medications, epilepsy surgery is a treatment alternative that offers the possibility of complete control of seizures and improved quality of life. Adverse medication effects and depression are readily identified by systematic use of reliable and valid instruments, and may be the most important negative influences on a person's perception of their current health status. Adequate education regarding relative risks of recurrent seizures compared to surgery, systematic screening for adverse medication effects and subsequent selection of appropriate antiepileptic drugs, and identification and treatment of depression should offer substantial improvement in overall health of persons with epilepsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971128     DOI: 10.1212/wnl.58.8_suppl_5.s9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

1.  Depression in Epilepsy Is Much More Than a Reactive Process.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

Review 2.  Neuropsychological and behavioral effects of antiepilepsy drugs.

Authors:  David W Loring; Susan Marino; Kimford J Meador
Journal:  Neuropsychol Rev       Date:  2007-10-18       Impact factor: 7.444

3.  Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2011-05       Impact factor: 7.500

4.  Depressive behavior and selective down-regulation of serotonin receptor expression after early-life seizures: reversal by environmental enrichment.

Authors:  Sookyong Koh; Rhamy Magid; Hyokwon Chung; Christy D Stine; Dawn N Wilson
Journal:  Epilepsy Behav       Date:  2007-02       Impact factor: 2.937

Review 5.  Seletracetam (UCB 44212).

Authors:  Barbara Bennett; Alain Matagne; Philippe Michel; Michèle Leonard; Miranda Cornet; Marie-Anne Meeus; Nathalie Toublanc
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

6.  A Trial of Sertraline or Cognitive Behavior Therapy for Depression in Epilepsy.

Authors:  Frank G Gilliam; Kevin J Black; Jewell Carter; Kenneth E Freedland; Yvette I Sheline; Wei-Yann Tsai; Patrick J Lustman
Journal:  Ann Neurol       Date:  2019-08-15       Impact factor: 10.422

Review 7.  Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Authors:  Andres M Kanner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

Review 8.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

Review 9.  The impact of epilepsy on subjective health status.

Authors:  Frank Gilliam
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

Review 10.  Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.

Authors:  J Mitchell Miller; Robert P Kustra; Alain Vuong; Anne E Hammer; John A Messenheimer
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.